Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NYSE | Common Stock
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology.
The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022.
GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 31, 24 | 1.09 Increased by +12.37% | 0.99 Increased by +10.10% |
| May 1, 24 | 1.09 Increased by +21.11% | 0.91 Increased by +19.78% |
| Jan 31, 24 | 0.72 Increased by +18.03% | 0.76 Decreased by -5.26% |
| Nov 1, 23 | 1.28 Increased by +16.36% | 1.14 Increased by +12.28% |
| Jul 26, 23 | 0.97 Increased by +11.49% | 0.87 Increased by +11.49% |
| Apr 26, 23 | 0.90 Decreased by -17.43% | 0.82 Increased by +9.76% |
| Jan 31, 23 | 0.61 Decreased by -29.07% | 0.50 Increased by +22.00% |
| Nov 1, 22 | 1.10 Decreased by -12.70% | 0.96 Increased by +14.58% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 8.15 B Increased by +4.06% | 1.46 B Increased by +87.93% | Increased by +17.97% Increased by +80.60% |
| Jun 30, 23 | 7.18 B Increased by +3.59% | 1.62 B Increased by +93.79% | Increased by +22.62% Increased by +87.07% |
| Mar 31, 23 | 6.95 B Decreased by -28.93% | 1.49 B Decreased by -17.31% | Increased by +21.44% Increased by +16.34% |
| Dec 31, 22 | 7.38 B Decreased by -22.58% | 1.50 B Increased by +99.60% | Increased by +20.27% Increased by +157.81% |
| Sep 30, 22 | 7.83 B Decreased by -13.75% | 779.00 M Decreased by -33.30% | Increased by +9.95% Decreased by -22.67% |
| Jun 30, 22 | 6.93 B Decreased by -14.37% | 838.00 M Decreased by -39.93% | Increased by +12.09% Decreased by -29.85% |
| Mar 31, 22 | 9.78 B Increased by +31.84% | 1.80 B Increased by +67.94% | Increased by +18.43% Increased by +27.38% |
| Dec 31, 21 | 9.53 B Increased by +9.02% | 749.00 M Increased by +10.64% | Increased by +7.86% Increased by +1.48% |